Skip to main content
TipRanks
Go Ultimate75% OFF

Spero Therapeutics (SPRO) Q4 2023 Earnings Report

604 Followers

SPRO Q4 2023 EPS Results

Actual EPS
$0.96
Consensus EPS
-$0.10
Beat/Miss
Beat by +$1.06
One Year Ago EPS
$0.55

SPRO Q4 2023 Revenue Results

Actual Revenue
$71.83M
Expected Revenue
$18.63M
Beat/Miss
Beat by +$53.19M
YoY Revenue Growth
+54.95%

Earnings Announcement Details

Quarter
Q4 2023
Date
03/13/2024
Time
After Close
Conference Call
Wednesday, March 13, 2024
SPRO Upcoming Earnings

Spero Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.

Q4 2023 Earnings Call Audio

SPRO Q4 2023 Earnings Call
0:00 / 0:00

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

SPRO Earnings History

SPRO earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 16, 20262026 (Q3)-0.47--0.13――
Aug 12, 20262026 (Q2)―-0.16-0.03-433.33% (-0.13)
May 13, 20262026 (Q1)―-0.13-0.2548.00% (+0.12)
Mar 26, 20262025 (Q4)-0.200.53-0.38239.47% (+0.91)
Nov 13, 20252025 (Q3)-0.25-0.13-0.3259.38% (+0.19)
Aug 12, 20252025 (Q2)-0.38-0.03-0.3390.91% (+0.30)
May 13, 20252025 (Q1)-0.55-0.25-0.24-4.17% (-0.01)
Mar 27, 20252024 (Q4)-0.31-0.380.96-139.58% (-1.34)
Nov 14, 20242024 (Q3)-0.27-0.32-0.06-433.33% (-0.26)
Aug 05, 20242024 (Q2)-0.38-0.33-0.23-43.48% (-0.10)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed